KALA
KalaGhazi | ObsEva SA @KalaGhazi
#ObsEva SA has been volatile last week
I do see an upside
Good luck
Reata PharmaceuticalsHi everyone, this is KalaGhazi and today I will be talking about Reata that just rocketed 200% yesterday.
Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease called Friedreich’s ataxia.
Shares of Reata have surged 200.3% in the past year against the industry’s 9.9% decline.
Reata’s new rare-disease drug will cost $370,000 per year.
Who on earth has the money for this treatment???
KALA SELL SELL SELL++++++OMG this garbage has been run up too fast by the pump n dump crowd! Look at KTRA, this is what happens to these up then back down to reality. Money losing FDA blah blah overvalued
Kala Pharma 450% gain incomingBanks has a lot of Long Hedges Open on these tickers, they have been overall short the last 1,5 years.
Now in March they began to close their first Long Hedge position.
Question right now is, did they build up big position yet for the longside, or they just sold their long Hedge and want price to go down further.
If we hold the lows of 0,59 here - no weekly close below and break the 0,93 lvl we should continue to the next Banks open Long Hedge at 2,66 from there on 1,68 should hold for price to continue to 4 $
Daily Short Parabolic Stock Ideas for my followers!! Follow Me I decided to start this new format to take advantage of short opportunities that arise when a week stock has gone parabolic.
I have some criteria to sift through opportunities and choose the best:
1) The company is relatively unknown (normally belongs to the OTC market) and financially weak (medical companies normally satisfy these criteria)
2) The company has been on a long downtrend
3) The company has made a large move to the upside (greater or equal to 15%; NEVER SPECULATE ON A COMPANY THAT HAS RISEN LESS THAN THAT IN FIRST DAY OF EXPLOSION). Also consider that the green explosion has to be from a relatively full green candle.
4) Before the upside movement, the chart should have formed a falling wedge (which it has broken after the first great upward movement)
5) After several days, an inversion pattern should form (most usually a double top) and that pattern can be used to short the stock according to standard rules
Short stocks to keep an eye on for short opportunities:
1) KALA
2) KAVL
3) COE
4) LBPS
KALA Levels + Short InfoShort squeeze stocks have become a favorite recently. KALA has started getting wrapped into the conversation. Looking at details from sites like FinViz, short float is around 20% meanwhile the float itself shows to be around 42 million shares. Plotting some levels, you'll notice that KALA is still in the lower channel on the fib retracement slowly heading toward the 786 area. However, before that happens, keep watch on an interim level around $3.40. It was previously a support level in July but seems to have become a resistance level as KALA was strongly rejected right at $3.40 on Friday. Aside from the technical/speculative trend, there are also a few things to watch with the company after a rough first half:
" Kala specializes in eye treatments. Its EYSUVIS is quickly playing a leading role for the company. According to the company, this past quarter, it was a preferred prescription for short-term treatment of dry eye disease. Furthermore, Kala explained that its expanding market access with Commercial and Medicare Part D health plans...Mark Iwicki, Chairman, President, and Chief Executive Officer of Kala Pharmaceuticals, explained, “We are encouraged by the very positive feedback we consistently receive from physicians and patients, who describe EYSUVIS as an effective and comfortable medicine and look forward to building on this foundation as we continue with the EYSUVIS launch. In parallel, we continue to promote INVELTYS and are advancing our pipeline of new chemical entities for front and back of the eye diseases, as we work to build a robust and sustainable portfolio of innovative treatments.” "
Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
KALA Technical Analysis 🧙Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
kala Pharmaceuticals Stock AnalysisKala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease
-- FDA Sets PDUFA Goal Date of October 30, 202
The idea is to go long hoping to get the good news from the FDA.
$KALA possible Cup & Handle BONASDAQ:KALA
KALA PHARMACEUTICALS INC $KALA is forming a CUP & Handle formation with a leading BO on the OBV index. The stock had also a lot of insider buying power and positive news with their EYSUVIS (a dry eye disease)
